SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 32.63 |
| Enterprise Value ($M) | 65.33 |
| Book Value ($M) | -45.39 |
| Book Value / Share | -0.88 |
| Price / Book | -0.72 |
| NCAV ($M) | -48.38 |
| NCAV / Share | -0.94 |
| Price / NCAV | -0.67 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.91 |
| Return on Equity (ROE) | -20.12 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.48 |
| Current Ratio | 0.48 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.73 |
| Assets | 7.72 |
| Liabilities | 53.11 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Singer Nicholas Jason | 9.99 | 7.73 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 359,932 | 1,924,538 | 18.70 | |
| 4,789,748 | 12,134,932 | 39.47 | |
| 224,592 | 1,327,033 | 16.92 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ENVB – Enveric Biosciences, Inc. | EPIX – ESSA Pharma Inc. |
| EQ – Equillium, Inc. | ESLA – Estrella Immunopharma, Inc. |
| EVOK – Evoke Pharma, Inc. |
Financial data and stock pages provided by
Fintel.io